about
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basisIdentifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesisMetabolism of the antibacterial triclocarban by human epidermal keratinocytes to yield protein adductsMolecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder CancerCreating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage.Directly coupled high-performance liquid chromatography-accelerator mass spectrometry measurement of chemically modified protein and peptidesAccelerator mass spectrometry-enabled studies: current status and future prospects.Calcium isolation from large-volume human urine samples for 41Ca analysis by accelerator mass spectrometry.Yeast dynamic metabolic flux measurement in nutrient-rich media by HPLC and accelerator mass spectrometry.Quantifying exploratory low dose compounds in humans with AMS.Human microdosing for the prediction of patient response.Accelerator mass spectrometry can be used to assess vitamin A metabolism quantitatively in boys in a community setting.New frontiers in science and technology: nuclear techniques in nutrition.Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceDetection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations.Recent advances in biomedical applications of accelerator mass spectrometry.Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy.Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.Diagnostic Microdosing Approach to Study Gemcitabine Resistance.Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review.A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts.To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.
P2860
Q24641921-1CD955E0-3DE3-4312-8201-7E3057D5B50DQ24656086-2F9E69F8-279F-40DD-81BC-D4C57970FAE2Q28392013-2D26F361-4685-4FA2-95E9-E91A3E51F73BQ28552735-46323CB4-EA23-47DF-9329-C05022D01FCBQ33501834-0BA42FA8-BCE8-43A2-97E3-CEAAFECF9B9DQ33664945-6690F958-50E1-4D52-9782-3D0F49B1EB9FQ33819361-26C1EEE0-8392-4DFD-AC59-4F4C85FA2076Q33871140-ADC6B964-F4EB-49C0-B8B0-1AFD249C7A60Q34372537-5E117919-463C-48A4-9218-0B083CA7D7CBQ34708648-A1C6D7FD-2A92-4968-BD9B-0CA0EC4368B8Q35041349-35F90966-FF37-4005-99BB-BBFF35E6AA0CQ35113990-92A31DF1-4D2E-4623-92D8-3814E37C4E05Q35125398-F0A0ADA5-8ECA-4F85-B3F6-C81AF716CCD3Q36786996-D15B1434-96FF-4BAD-9B8E-021C830C88C5Q36868478-6EFC337D-31A7-41DF-BC57-A09B8CFBECF0Q37266360-9CE8CF06-8DCC-4923-B0B2-31373C540870Q37600860-15190CAB-8356-4D12-8241-954A8925E709Q37964571-74E32A1A-5040-43F5-9E4B-3C1CCFFD1EA6Q38744400-58F82F56-6BED-441C-831B-31D4C654FE49Q38836158-161B4C25-DAA4-446B-949F-1E7A344FF397Q46937815-934F7107-142C-4BE8-95B3-3E3D075C97D4Q50871327-48F76124-DC25-4863-BA9C-D42E4640A5DEQ53103001-AE0340A9-1EF8-44FF-A5B5-ABA14F9361BA
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Accelerator mass spectrometry for biomedical research.
@ast
Accelerator mass spectrometry for biomedical research.
@en
Accelerator mass spectrometry for biomedical research.
@nl
type
label
Accelerator mass spectrometry for biomedical research.
@ast
Accelerator mass spectrometry for biomedical research.
@en
Accelerator mass spectrometry for biomedical research.
@nl
prefLabel
Accelerator mass spectrometry for biomedical research.
@ast
Accelerator mass spectrometry for biomedical research.
@en
Accelerator mass spectrometry for biomedical research.
@nl
P1476
Accelerator mass spectrometry for biomedical research
@en
P2093
Karen H Dingley
Kenneth W Turteltaub
P304
P356
10.1016/S0076-6879(05)02014-8
P407
P50
P577
2005-01-01T00:00:00Z